Science and Medicine: a Life’s Work
"Women In is a series of portraits of women who, by way of their career path, personalities or commitments, are involved – with talent – in all areas of their company or even society at large. Although we celebrate women on 8 March every year, we felt it was important to devote a little more time and space to them before and after that symbolic date in order to highlight the diversity of their trajectories and emphasise the power of their impact on society."
Since 2018, Societe Generale Private Banking has been a partner of Institut Curie and supports the construction of the SIREDO centre dedicated to innovation and research in child, adolescent and young adult oncology. Through our solutions in support of charitable causes, we are proud to have raised €2 million to finance research and treatment to combat paediatric cancers.
In honour of International Women’s Day, the “Au Féminin by SGPB” club has put together a series of interviews to highlight women who are an inspiration in their field. The club began three years ago to help women navigate decisions around their finances and wealth management. Marceline Try, Business Development Manager at Societe Generale Private Banking, met with Dr. Sarah Watson, Clinician Scientist in medical oncology at Institut Curie.
Sarah Watson
Clinician Scientist in medical oncology at Institut Curie
After completing a double degree in medicine and science at the former Pierre and Marie Curie University and the École Normale Supérieure (ENS), Sarah did her medical oncology residency and PhD in science at Institut Curie. In 2017, she was awarded the first CCA-Inserm-Bettencourt clinical fellowship, granting her 50% protected time for her clinical training and 50% protected time for her scientific research. Her clinical work focuses on the medical care of patients with sarcomas and other mesenchymal tumours. As a scientist, her focus is the molecular characterisation of high-grade adult sarcomas and cancers of unknown primary origin. She also received the Gallet and Breton Prize from the French National Academy of Medicine, as well as the Claude Jacquillat Prize from the French Cancer Society.
Marceline Try, Business Development Manager
Sarah, what would you say characterises your career?
I would start by saying that I am a multidisciplinary person. I did not enrol or train in one area, but in many. I chose both medicine and research at the ENS because they are complementary disciplines — scientists need to understand doctors, and doctors should inspire research. The experience I accumulate in the laboratory and with my patients help me to grow and become more competent as both a researcher and oncologist.
The next word that comes to mind is “work”. I am engrossed in my work. I think about it all the time. It is what gives meaning to my life. My role as a researcher does not end when I leave my laboratory; my patients stay with me, and I stay with them.
Then, there is an element of chance or luck. My career has allowed me to meet people and encounter situations that I may not have otherwise. I am deeply grateful to everyone I have met along the way — colleagues, students, lecturers, friends, family — for helping shape the person I am today.
What are you most proud of right now?
I would say the doctors, researchers and students I have rallied around me. We form a tight-knit and supportive team that works collectively on the medical and scientific issues that unite us. By believing in ourselves we have been given the means to move forward. I'm also proud of my work and the way in which I make it meaningful, while doing my part as a researcher. I feel that what I do is useful for my patients and their families, especially for cancer treatment and dealing with death and end of life.
Is recognition important to you?
You know, recognition is fairly indirect in my line of work. Recognition comes from your colleagues and superiors, but also from your publications and the exposure of your scientific research. But I’m more sensitive to recognition from my patients; it gives my work and my life meaning. Providing relief and helping patients improve their health are powerful drivers when it comes to recognition.
What inspires you today?
My love for my job and my work — as you will have guessed! But also my dual careers, looking at my double degree. However, I'm less about the “what” and more about the “who” in this regard, and for that figures like Simone Veil inspire me enormously. For her journey, both in her private life and her career, her strong moral fibre, her family values and her political engagement. But more than anything, her resilience and her ability to rise above hardship resonate with me the most. I am a firm believer in how hardship and difficulty can serve as a springboard. I try to remember this in my career and in everyday life.
What do you think is the biggest problem facing women of your generation?
I don't think there is a generational or gender inequality problem today in my environment. While research and medicine remain historically male-dominated fields, the statistics are showing good progress. Everyone now knows that more doctors in France means more women, and here things are also moving the right direction.
On a more personal note, I have noticed that many women, including myself, experience “imposter syndrome”, which can stand in the way of professional fulfilment. I believe that the problem lies with ourselves, not with others. It is up to each individual to take charge, just as you would to build self-confidence.
To conclude, what are the major challenges ahead for your sector?
I could talk to you about Artificial Intelligence (AI), new technologies, or the major questions facing society, but I am more inspired by a challenge of life. My challenge, like that of my teams, is to improve people's daily lives in the face of illness. My challenge is to assist my patients, to stand by them over the long term, and to fight for my teams, my patients and all those who place their trust in us.
DISCLAIMER :
This document has no contractual value. It is not intended to provide an investment service such as investment advice, a related investment service, arbitration advice or legal, accounting or tax advice from Société Générale Private Banking France (‘SGPB France’), which cannot therefore be held liable for any decision taken by an investor solely on the basis of its content. SGPB France undertakes neither to update nor to modify it.
Before making any investment decision, please review the details of the documentation for the service or product being considered, including any associated risks, and consult your legal and tax advice. If the document is consulted by a French tax non-resident, he or she will have to ensure with his or her legal and tax advisors that he or she complies with the legal and regulatory provisions of the jurisdiction concerned. It is not intended for distribution in the United States, or to a U.S. tax resident, or to any person or jurisdiction for which such distribution would be restricted or unlawful.
The past performance information that may be reproduced is not intended to guarantee future performance. These future performances are therefore indicative. The return to investors will vary depending on market performance and the shelf life of the investment. Future performance may be subject to tax, which depends on your present and future personal situation.
Societe Generale has put in place a policy to manage conflicts of interest. SGPB France has put in place (i) a policy to handle complaints made by its customers, available on request from your private banker or on its website and (ii) a policy to protect personal data (https://www.privatebanking.societegenerale.com/fr/protection-donnees-personnelles/). At any time and without charge, you have the right to access, rectify, limit processing, erase your data and the right to object to their use for the purposes of commercial prospecting by contacting our Data Protection Officer by email (protectiondesdonnees@societegenerale.fr). In the event of a dispute, you can lodge a complaint with the Commission Nationale de l’Informatique et des Libertés (CNIL), the supervisory authority responsible for compliance with personal data obligations.
This document is issued by Societe Generale, a French bank authorized and supervised by the Prudential Control and Resolution Authority, located at 4 Place de Budapest, 75436 Paris Cedex 09, under the prudential supervision of the European Central Bank (‘ECB’) and registered with ORIAS as an insurance intermediary under number 07 022 493, orias.fr. Societe Generale is a French public limited company with a capital of EUR 1 003 724 927.50 on 17 November 2023, whose registered office is located at 29 boulevard Haussmann, 75009 Paris, and whose unique identification number is 552 120 222 R.C.S. Paris (ADEME FR231725_01YSGB). More details are available on request or at www.privatebanking.societegenerale.com/. This document may not be communicated or reproduced in whole or in part, without the prior written consent of SGPB France.
In honour of International Women’s Day, the “Au Féminin by SGPB” club has put together a series of interviews to...
In honour of International Women’s Day, the “Au Féminin by SGPB” club has put together a series of interviews to...
Bees play an essential role in our ecosystem since they are responsible for the pollination of 75% of fruit and...
This content is not available in English